Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model. Serra R, Zhao T, Huq S, Gorelick NL, et al. PLoS One 2021;16:e0251957.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Serra R, Zhao T, Huq S, Gorelick NL, et al. Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model. PLoS One 2021;16:e0251957.
PMID: 34731160